Clinical features | MiR-98 | MiR-101 | MiR-214 | ||||||
---|---|---|---|---|---|---|---|---|---|
High | Low | P | High | Low | P | High | Low | P | |
Total | 20 | 20 | Â | 13 | 27 | Â | 12 | 28 | Â |
Age (year) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 <60 | 7 | 9 | 0.519 | 7 | 9 | 0.215 | 4 | 12 | 0.573 |
 ≥60 | 13 | 11 |  | 6 | 18 |  | 8 | 16 |  |
Gender | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Male | 16 | 12 | 0.168 | 7 | 21 | 0.122 | 8 | 20 | 0.763 |
 Female | 4 | 8 |  | 6 | 6 |  | 4 | 8 |  |
Pathological grading | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Well | 11 | 2 | 0.004 | 7 | 6 | 0.135 | 8 | 5 | 0.010 |
 Moderately | 6 | 7 |  | 3 | 10 |  | 2 | 11 |  |
 Poorly | 3 | 11 |  | 3 | 11 |  | 2 | 12 |  |
Tumor location | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Upper1/3-middle1/3 | 15 | 12 | 0.311 | 8 | 19 | 0.576 | 9 | 18 | 0.507 |
 Lower1/3 | 5 | 8 |  | 5 | 8 |  | 3 | 10 |  |
Tumor stage | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 T1/T2 | 12 | 3 | 0.003 | 9 | 6 | 0.004 | 8 | 7 | 0.013 |
 T3/T4 | 8 | 17 |  | 4 | 21 |  | 4 | 21 |  |
Lymph node metastasis | Â | Â | Â | Â | Â | Â | Â | ||
 Negative | 13 | 4 | 0.004 | 9 | 8 | 0.018 | 8 | 9 | 0.043 |
 Positive | 7 | 16 |  | 4 | 19 |  | 4 | 19 |  |